Loeffler Endocarditis Workup
- Author: Sohail A Hassan, MD; Chief Editor: Richard A Lange, MD, MBA more...
CBC counts should be performed to look for the presence of eosinophils. Peripheral eosinophilia should not be considered mandatory for the diagnosis of Loeffler endocarditis, as described by Priglinger et al.
Cytogenetics, fluorescent in situ hybridization (FISH), and molecular analysis show the presence of the FIP1L1-PDGFRA fusion gene as demonstrated by Cools et al and Rotoli et al.[18, 20]
ECG, echocardiography, Doppler studies using echocardiogram, cardiac catheterization, endomyocardial biopsy, and CT scan or MRI of the chest may all be useful in diagnosis, as for cardiomyopathy of any cause.
The echocardiographic hallmark of Loeffler endocarditis includes a restrictive pattern of filling with relatively preserved left ventricular systolic function, as reported by Parillo et al.[31, 32]
Localized thickening of the basal posterior wall of the left ventricular free wall and restricted motion of the posterior leaflet of the mitral valve are seen, as reported by Spyrou et al and Child et al.[33, 34]
Apical thrombus in the left ventricle also has been reported. Also, presentation with restriction of the mitral apparatus with a large thrombus has been reported.
Regurgitant AV valve lesions are often present.
Recurrent thrombosis of the prosthetic mitral valve in the setting of rising eosinophilia has been reported.[35, 36]
Three echocardiographic features of amyloidosis, another cause of restrictive cardiomyopathy, include thickened interatrial septum; thickening of the cardiac valves; and granular, sparkling texture of the myocardium. All may be present in amyloidosis but not in Loeffler endocarditis.
Echocardiographic Doppler findings are of restrictive cardiomyopathy, including decreased right ventricular and left ventricular velocities with inspiration and inspiratory augmentation of hepatic-vein diastolic flow reversal.
Cardiac catheterization reveals markedly elevated ventricular filling pressures and the presence of mitral or tricuspid regurgitation.
On left ventriculography, a characteristic feature is preserved left ventricular systolic function with obliteration of the left ventricular apex, as reported by Weller and associates.
The hemodynamic picture on cardiac pressure tracings reveals a restrictive picture due to dense endocardial scarring and a reduction in left ventricular cavity caused by an organized thrombus, as reported by Weller et al and Parillo et al.[24, 31] The hemodynamic picture may include elevation of left ventricular end diastolic pressure, often greater than 5 mm Hg over right ventricular end diastolic pressure; however the pressures may be identical at times.
Cardiac Magnetic Resonance Imaging
Cardiac MRI findings of endomyocardial fibrosis include right ventricular diastolic dysfunction, mild systolic dysfunction, and extensive subendocardial delayed contrast enhancement.
Hybrid positron emission tomography/MRI (PET-MRI) has the potential to be useful in confirming the diagnosis of Loeffler endocarditis and the progression of inflammatory activity in affected patients.
ECG shows nonspecific ST-segment and T-wave abnormalities as reported by Spyrou et al and Arnold et al.[33, 39]
Arrhythmia, especially atrial fibrillation, and conduction system defects, particularly right-bundle branch block, may be present, as reported by Fawzy et al.
Nonspecific findings may include pseudo infarction patterns of left-axis deviation.
Percutaneous endomyocardial biopsy often confirms diagnosis. As endomyocardial involvement may be patchy, a false-negative biopsy result also is possible, as reported by Felice and colleagues.
Histologic specimens of the myocardial biopsy reveal thick and deep layers of loosely arranged collagen tissue, which, although localized primarily to the endocardium, may have strands extending into the underlying myocardium. Although peripheral eosinophilia is characteristic of Loeffler endocarditis, eosinophilic infiltration of the tissues and arteries is less common, possibly because of the infrequency of biopsy.
Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation. 1996 Mar 1. 93(5):841-2. [Medline].
Gotlib J. World Health Organization-defined eosinophilic disorders: 2011 update on diagnosis, risk stratification, and management. Am J Hematol. 2011 Aug. 86(8):677-88. [Medline].
Loeffler W. Endocarditis parietalis fibroplastica mit Blut-eosinophilie, ein eigenartiges Krankheitshild. Schweiz Med Wochenschr;. 1936. 66:817-820.
Oakley CM, Olsen GJ. Eosinophilia and heart disease. Br Heart J. 1977 Mar. 39(3):233-7. [Medline].
Herzog CA, Snover DC, Staley NA. Acute necrotising eosinophilic myocarditis. Br Heart J. 1984 Sep. 52(3):343-8. [Medline].
Tonnesen P, Teglbjaerg CS. An "unexpected" fatal case of the hypereosinophilic syndrome. Eur J Respir Dis. 1984 Jul. 65(5):389-93. [Medline].
Kim CH, Vlietstra RE, Edwards WD, et al. Steroid-responsive eosinophilic myocarditis: diagnosis by endomyocardial biopsy. Am J Cardiol. 1984 May 15. 53(10):1472-3. [Medline].
Isaka N, Araki S, Shibata M, et al. Reversal of coronary artery occlusions in allergic granulomatosis and angiitis (Churg-Strauss syndrome). Am Heart J. 1994 Sep. 128(3):609-13. [Medline].
Seshadri S, Narula J, Chopra P. Asymptomatic eosinophilic myocarditis: 2 + 2 = 4 or 5!. Int J Cardiol. 1991 Jun. 31(3):348-9. [Medline].
Solley GO, Maldonado JE, Gleich GJ, et al. Endomyocardiopathy with eosinophilia. Mayo Clin Proc. 1976 Nov. 51(11):697-708. [Medline].
Olsen EG, Spry CJ. Relation between eosinophilia and endomyocardial disease. Prog Cardiovasc Dis. 1985 Jan-Feb. 27(4):241-54. [Medline].
Priglinger U, Drach J, Ullrich R, et al. Idiopathic eosinophilic endomyocarditis in the absence of peripheral eosinophilia. Leuk Lymphoma. 2002 Jan. 43(1):215-8. [Medline].
Tai PC, Ackerman SJ, Spry CJ, et al. Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease. Lancet. 1987 Mar 21. 1(8534):643-7. [Medline].
Spry CJ, Tai PC, Davies J. The cardiotoxicity of eosinophils. Postgrad Med J. 1983 Mar. 59(689):147-53. [Medline].
Gleich GJ, Frigas E, Loegering DA, et al. Cytotoxic properties of the eosinophil major basic protein. J Immunol. 1979 Dec. 123(6):2925-7. [Medline].
Slungaard A, Vercellotti GM, Tran T, et al. Eosinophil cationic granule proteins impair thrombomodulin function. A potential mechanism for thromboembolism in hypereosinophilic heart disease. J Clin Invest. 1993 Apr. 91(4):1721-30. [Medline].
Cunningham K, Davies RA, Catching J, Veinot JP. Pathologic quiz case: a young woman with eosinophilia and heart failure. Primary hypereosinophilic syndrome with loeffler endocarditis. Arch Pathol Lab Med. 2005 Jan. 129(1):e29-30. [Medline].
Cools J, DeAngelo DJ, Gotlib J, et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med. 2003 Mar 27. 348(13):1201-14. [Medline].
Vandenberghe P, Wlodarska I, Michaux L, et al. Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias. Leukemia. 2004 Apr. 18(4):734-42. [Medline].
Rotoli B, Catalano L, Galderisi M, et al. Rapid reversion of Loeffler's endocarditis by imatinib in early stage clonal hypereosinophilic syndrome. Leuk Lymphoma. 2004 Dec. 45(12):2503-7. [Medline].
Alderman EL. Non-infective endocardial disease. Cardiovascular Disease. 1999. 1-7.
Bestetti RB, Corbucci HA, Fornitano LD, et al. Angina-like chest pain and syncope as the clinical presentation of left ventricular endomyocardial fibrosis: a case report. Angiology. 2005 May-Jun. 56(3):339-42. [Medline].
Coelho-Filho OR, Mongeon FP, Mitchell RN, Blankstein R, Jerosch-Herold M, Kwong RY. Images in cardiovascular medicine. Loeffler endocarditis presenting with recurrent polymorphic ventricular tachycardia diagnosed by cardiac magnetic resonance imaging. Circulation. 2010 Jul 6. 122(1):96-9. [Medline].
Weller PF, Bubley GJ. The idiopathic hypereosinophilic syndrome. Blood. 1994 May 15. 83(10):2759-79. [Medline].
Maruyoshi H, Nakatani S, Yasumura Y, et al. Loffler's endocarditis associated with unusual ECG change mimicking posterior myocardial infarction. Heart Vessels. 2003 Mar. 18(1):43-6. [Medline].
Mor A, Segev A, Hershkovits R, et al. Hypereosinophilic syndrome presenting as acute myocardial infarction. Allergy. 2000 Sep. 55(9):899-900. [Medline].
Gudmundsson GS, Ohr J, Leya F, et al. An unusual case of recurrent Loffler endomyocarditis of the aortic valve. Arch Pathol Lab Med. 2003 May. 127(5):606-9. [Medline].
Niemeijer ND, van Daele PL, Caliskan K, Oei FB, Loosveld OJ, van der Meer NJ. Loffler endocarditis: a rare cause of acute cardiac failure. J Cardiothorac Surg. 2012 Oct 10. 7:109. [Medline]. [Full Text].
Klag T, Schnetzke U, Benz R, et al. Leriche's syndrome and Loffler endocarditis in a 30-year-old patient presenting with hypereosinophilic syndrome. Ann Hematol. 2012 Jan. 91(1):139-41. [Medline].
Simonnet B, Jacquier A, Salaun E, Hubert S, Habib G. Cardiac involvement in hypereosinophilic syndrome: role of multimodality imaging. Eur Heart J Cardiovasc Imaging. 2014 Oct 9. [Medline].
Parrillo JE. Heart disease and the eosinophil. N Engl J Med. 1990 Nov 29. 323(22):1560-1. [Medline].
Del Bene MR, Cappelli F, Rega L, Venditti F, Barletta G. Characterization of Loeffler Eosinophilic Myocarditis by Means of Real Time Three-Dimensional Contrast-Enhanced Echocardiography. Echocardiography. 2011 Nov 8. [Medline].
Spyrou N, Foale R. Restrictive cardiomyopathies. Curr Opin Cardiol. 1994 May. 9(3):344-8. [Medline].
Child JS, Perloff JK. The restrictive cardiomyopathies. Cardiol Clin. 1988 May. 6(2):289-316. [Medline].
Watanabe K, Tournilhac O, Camilleri LF. Recurrent thrombosis of prosthetic mitral valve in idiopathic hypereosinophilic syndrome. J Heart Valve Dis. 2002 May. 11(3):447-9. [Medline].
Zakhama L, Slama I, Boussabah E, Harbegue B, Mimouni M, Abdelaali N, et al. Recurrent native and prosthetic mitral valve thrombosis in idiopathic hypereosinophilic syndrome. J Heart Valve Dis. 2014 Mar. 23(2):168-70. [Medline].
Paydar A, Ordovas KG, Reddy GP. Magnetic resonance imaging for endomyocardial fibrosis. Pediatr Cardiol. 2008 Sep. 29(5):1004-5. [Medline].
Langwieser N, von Olshausen G, Rischpler C, Ibrahim T. Confirmation of diagnosis and graduation of inflammatory activity of Loeffler endocarditis by hybrid positron emission tomography/magnetic resonance imaging. Eur Heart J. 2014 Sep 21. 35(36):2496. [Medline].
Arnold M, McGuire L, Lee JC. Loeffler's fibroplastic endocarditis. Pathology. 1988 Jan. 20(1):79-82. [Medline].
Fawzy ME, Ziady G, Halim M, et al. Endomyocardial fibrosis: report of eight cases. J Am Coll Cardiol. 1985 Apr. 5(4):983-8. [Medline].
Felice PV, Sawicki J, Anto J. Endomyocardial disease and eosinophilia. Angiology. 1993 Nov. 44(11):869-74. [Medline].
Uetsuka Y, Kasahara S, Tanaka N, et al. Hemodynamic and scintigraphic improvement after steroid therapy in a case with acute eosinophilic heart disease. Heart Vessels Suppl. 1990. 5:8-12. [Medline].
Butterfield JH, Gleich GJ. Interferon-alpha treatment of six patients with the idiopathic hypereosinophilic syndrome. Ann Intern Med. 1994 Nov 1. 121(9):648-53. [Medline].
Tanaka H, Kawai H, Tatsumi K, Kataoka T, Onishi T, Yokoyama M, et al. Surgical treatment for Loffler's Endocarditis with left ventricular thrombus and severe mitral regurgitation: a case report. J Cardiol. April, 2006. 47 (4):207-13. [Medline].
Jategaonkar S, Butz T, Faber L. [Surgical treatment of the hypereosinophilic syndrome with cardiac involvement (Loffler's endocarditis)]. Dtsch Med Wochenschr. Mar. 2007. 7133(12):50-52. [Medline].